Browsing Tag
C2N Diagnostics LLC
1 post
C2N Diagnostics wins FDA clearance for PrecivityAD2 as Alzheimer’s blood testing race widens
C2N Diagnostics has secured FDA clearance for PrecivityAD2, extending regulated Alzheimer’s blood testing to symptomatic adults as young as 40 and intensifying competition with established diagnostic platforms.